Literature DB >> 8177983

Regulation of parathyroid hormone synthesis and secretion.

J Silver1, T Naveh-Many.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 8177983

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


× No keyword cloud information.
  7 in total

1.  The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism.

Authors:  J Fox; S H Lowe; R L Conklin; E F Nemeth
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

Review 2.  Vitamin D and its analogs in chronic renal failure.

Authors:  E Slatopolsky; A J Brown
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Polymorphisms of the vitamin D receptor and their effect on bone mass density in patients with normocalcemic hyperparathyroidism.

Authors:  Jose Luis Perez Castrillón; Gonzalo Díaz-Soto; Olatz Izaola Jauregui; Enrique Romero; Daniel de Luis Román
Journal:  Endocrine       Date:  2015-04-21       Impact factor: 3.633

4.  Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease?

Authors:  Mingxin Wei; Khaled Esbaei; Joanne M Bargman; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

5.  Bridging adults and paediatrics with secondary hyperparathyroidism receiving haemodialysis: a pharmacokinetic-pharmacodynamic analysis of cinacalcet.

Authors:  Ping Chen; Winnie Sohn; Adimoolam Narayanan; Per Olsson Gisleskog; Murad Melhem
Journal:  Br J Clin Pharmacol       Date:  2019-04-25       Impact factor: 4.335

6.  Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.

Authors:  Min Seok Cho; Kyun Sang Lee; Youn Kyoung Lee; Seong Kwon Ma; Jeong Hee Ko; Soo Wan Kim; Nam Ho Kim; Ki Chul Choi
Journal:  Korean J Intern Med       Date:  2002-06       Impact factor: 2.884

7.  An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis.

Authors:  Winnie Y Sohn; Anthony A Portale; Isidro B Salusky; Hao Zhang; Lucy L Yan; Bella Ertik; Shahnaz Shahinfar; Edward Lee; Bastian Dehmel; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2018-08-23       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.